...
首页> 外文期刊>Vaccine >Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
【24h】

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets

机译:在小鼠乳腺肿瘤发育早期鉴定的肿瘤相关抗原可以是有效的疫苗靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer vaccines composed of antigens identified by serological analysis of cDNA expression libraries (SEREX) induce antigen specific immune responses in patients but have had disappointing clinical benefits. While many attempts to modify the adjuvants and vaccine method have been tried, one issue not addressed was whether the SEREX tumor-associated antigens identified from late stages of disease were ideal targets. We questioned in the transgenic TgMMTV-neu mouse model whether the antigen repertoire is distinct between early and late stage breast cancer and whether the antigens identified via SEREX from transgenic mice with early or late stage tumors would elicit differential anti-tumor effects to address this question.
机译:由CDNA表达库(Serex)血清学分析鉴定的抗原组成的乳腺癌疫苗诱导患者抗原特异性免疫应答,但尚未令人失望的临床效益。 虽然已经尝试了许多尝试修饰佐剂和疫苗方法,但没有解决的一个问题是从疾病的后期鉴定的Serex肿瘤相关抗原是理想的靶标。 我们质疑在转基因TGMMTV-Neu鼠标模型中是否抗原曲目在早期和晚期乳腺癌之间是不同的,以及是否通过早期或晚期肿瘤的转基因小鼠通过Serex鉴定的抗原会引起差异的抗肿瘤效应来解决这个问题 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号